Side Letters in Venture Capital Financing: Drafting and Negotiating, Implications on Future Financing, Potential Traps
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE webinar will explore the use of side letters in venture capital financing transactions. The panel will discuss the role side letters play in venture capital financing, how these letters operate functionally, drafting and negotiating considerations, rights that are typically included or requested by investors, the implications these letters have on future financing rounds, a sale or an exit event, and potential pitfalls to avoid.
Outline
- Common and evolving uses of side letters in venture capital financing
- How side letters in venture capital financing differ from side letters in the private equity context
- Common requests in venture capital side letters
- Key considerations when reviewing, negotiating, structuring, and drafting side letters
- Side letters and their interplay with National Venture Capital Association (NVCA) governance documents
- Potential impact of side letters on future financing rounds or sale or exit event
- Potential traps and pitfalls with side letters
- Practitioner pointers and key takeaways
Benefits
The panel will discuss these and other key considerations:
- What are the current trends in the use of side letters in venture capital transactions?
- What are common rights investors want included in a venture capital side letter?
- How can side letters impact future financing rounds or a sale or exit event?
- What are key considerations and pitfalls to avoid when reviewing, negotiating, or drafting the substantive provisions in side letters?
Faculty

John Hutar
Partner
DLA Piper US
Mr. Hutar has nearly a decade of experience advising high-growth technology companies on corporate and securities... | Read More
Mr. Hutar has nearly a decade of experience advising high-growth technology companies on corporate and securities matters, including pre-incorporation planning, general corporate financing, venture capital financing, and mergers and acquisitions. He also represents venture capital funds, growth equity funds, and strategic investors in transactions of all sizes.
Close
James B. Jumper
Partner
Troutman Pepper Locke
Mr. Jumper leads transactions for public and private companies and equity funds in stock and asset acquisitions,... | Read More
Mr. Jumper leads transactions for public and private companies and equity funds in stock and asset acquisitions, dispositions, mergers, joint ventures, and strategic alliance arrangements. He also represents private equity funds, venture capitalists, and emerging companies in private placements, venture capital, and other capital-raising deals. Mr. Jumper advises corporate boards of directors and other senior stakeholders on day-to-day legal issues in areas such as governance, strategic matters, contract review, and other commercial issues. He is experienced in sectors such as life sciences, health care technology, pharmaceutical, insurance, energy, and food and beverage, among others.
Close
Lindsay Karas Stencel
Partner
Thompson Hine
Ms. Stencel is a partner in the firm’s New Ventures practice. She advises entrepreneurs, investors and fund... | Read More
Ms. Stencel is a partner in the firm’s New Ventures practice. She advises entrepreneurs, investors and fund managers on venture capital and startup matters, venture capital fund formation, mergers and acquisitions, corporate finance, federal and state securities filings and compliance, including public and private securities offerings, and corporate organization and governance matters. Prior to joining the firm, Ms. Stencel served as a partner and chief legal counsel at a Midwest-focused venture capital firm that invests in pre-seed, seed early stage and growth stage technology companies serving several industries. There, her efforts primarily focused on deal structuring, portfolio management, limited partner relations, fundraising and exit transactions.
CloseEarly Discount (through 03/14/25)